Rocco L Gemma

Title: Rocco L Gemma: Innovator in Pharmaceutical Compositions

Introduction

Rocco L Gemma is a notable inventor based in Dover, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for thyroid hormone drugs. With a total of 3 patents, his work has had a meaningful impact on the medical community.

Latest Patents

Rocco's latest patents include innovative methods of administering levothyroxine pharmaceutical compositions. This invention relates to stable pharmaceutical compositions and methods for making and administering such compositions. One aspect of his invention features stabilized pharmaceutical compositions that include active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium, preferably in an immediate release solid dosage form. Additionally, he has developed stabilized pharmaceutical and thyroid hormone compositions that utilize β-sheet microcrystalline cellulose, which improves potency life and methods of preparation.

Career Highlights

Throughout his career, Rocco has worked with various companies, including Jones Pharma, Inc. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry. His innovative approaches have contributed to advancements in the formulation of thyroid hormone medications.

Collaborations

Rocco has collaborated with notable professionals in the field, including G Andrew Franz and Elaine A Strauss. These collaborations have further enhanced the quality and effectiveness of his inventions.

Conclusion

Rocco L Gemma's contributions to pharmaceutical innovations, particularly in thyroid hormone compositions, demonstrate his commitment to improving medical treatments. His patents reflect a dedication to enhancing the stability and efficacy of essential medications.